+
Open data
-
Basic information
| Entry | ![]() | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Title | Structure of BA.4-S-RBD/Ab#10-M30W-S94M | |||||||||
Map data | ||||||||||
Sample |
| |||||||||
Keywords | SARS-CoV-2 / VIRAL PROTEIN | |||||||||
| Biological species | ![]() Homo sapiens (human) | |||||||||
| Method | single particle reconstruction / cryo EM / Resolution: 3.6 Å | |||||||||
Authors | Du J / Pallesen J | |||||||||
| Funding support | United States, 2 items
| |||||||||
Citation | Journal: Res Sq / Year: 2026Title: Structure-Guided Design of Therapeutic Antibodies Targeting SARS-CoV-2 Omicron Variants. Authors: Jesper Pallesen / Jianqiu Du / Yuanhan Wu / Sukanya Ghosh / Kelly Bayruns / Roopak Sadeesh / David Weiner Abstract: The ongoing evolution of SARS-CoV-2, particularly the emergence of Omicron subvariants, compromised the effectiveness of many therapeutic antibodies. In this study, we employed a structure-guided ...The ongoing evolution of SARS-CoV-2, particularly the emergence of Omicron subvariants, compromised the effectiveness of many therapeutic antibodies. In this study, we employed a structure-guided computational design strategy to systematically optimize the COV2-2196 antibody for improved neutralization of Omicron variants. Through iterative rounds of computational design and experimental validation, we identified key paratope mutations that restored and enhanced antibody binding and neutralization potency against resistant viral strains. Cryo-EM structural analysis revealed the molecular basis for these improvements, highlighting how targeted modifications can accommodate epitope changes introduced by viral evolution. Our approach demonstrates that effective antibody optimization can be achieved using accessible computational resources, providing a practical framework for rapid therapeutic development. These findings underscore the potential of structure-based design to address challenges posed by viral antigenic drift and support the development of broadly effective antibody therapeutics for emerging infectious diseases. | |||||||||
| History |
|
-
Structure visualization
| Supplemental images |
|---|
-
Downloads & links
-EMDB archive
| Map data | emd_77348.map.gz | 427.3 MB | EMDB map data format | |
|---|---|---|---|---|
| Header (meta data) | emd-77348-v30.xml emd-77348.xml | 17.7 KB 17.7 KB | Display Display | EMDB header |
| Images | emd_77348.png | 43.9 KB | ||
| Filedesc metadata | emd-77348.cif.gz | 6 KB | ||
| Others | emd_77348_half_map_1.map.gz emd_77348_half_map_2.map.gz | 474.6 MB 474.6 MB | ||
| Archive directory | http://ftp.pdbj.org/pub/emdb/structures/EMD-77348 ftp://ftp.pdbj.org/pub/emdb/structures/EMD-77348 | HTTPS FTP |
-Related structure data
-
Links
| EMDB pages | EMDB (EBI/PDBe) / EMDataResource |
|---|
-
Map
| File | Download / File: emd_77348.map.gz / Format: CCP4 / Size: 512 MB / Type: IMAGE STORED AS FLOATING POINT NUMBER (4 BYTES) | ||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Projections & slices | Image control
Images are generated by Spider. | ||||||||||||||||||||||||||||||||||||
| Voxel size | X=Y=Z: 1.06 Å | ||||||||||||||||||||||||||||||||||||
| Density |
| ||||||||||||||||||||||||||||||||||||
| Symmetry | Space group: 1 | ||||||||||||||||||||||||||||||||||||
| Details | EMDB XML:
|
-Supplemental data
-Half map: #1
| File | emd_77348_half_map_1.map | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Projections & Slices |
| ||||||||||||
| Density Histograms |
-Half map: #2
| File | emd_77348_half_map_2.map | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Projections & Slices |
| ||||||||||||
| Density Histograms |
-
Sample components
-Entire : Complex of SARS-CoV-2 Omicron BA.4 spike protein and Ab#10-M30W-S...
| Entire | Name: Complex of SARS-CoV-2 Omicron BA.4 spike protein and Ab#10-M30W-S94M IgG |
|---|---|
| Components |
|
-Supramolecule #1: Complex of SARS-CoV-2 Omicron BA.4 spike protein and Ab#10-M30W-S...
| Supramolecule | Name: Complex of SARS-CoV-2 Omicron BA.4 spike protein and Ab#10-M30W-S94M IgG type: complex / ID: 1 / Parent: 0 / Macromolecule list: all |
|---|---|
| Source (natural) | Organism: ![]() |
-Macromolecule #1: Ab#10-M30W-S94M heavy chain
| Macromolecule | Name: Ab#10-M30W-S94M heavy chain / type: protein_or_peptide / ID: 1 / Number of copies: 1 / Enantiomer: LEVO |
|---|---|
| Source (natural) | Organism: Homo sapiens (human) |
| Molecular weight | Theoretical: 52.014645 KDa |
| Recombinant expression | Organism: Homo sapiens (human) |
| Sequence | String: MDWTWRILFL VAAATGTHAQ MQLVQSGPEV KKPGTSVKVS CKASGFTFWS SAVQWVRQAR GQRLEWIGWI VIASGETNYA QKFQERVTI TRDMSTSTAY MELSSLRSED TAVYYCAAPY CSSRECNNGF DIWGQGTMVT VSSASTKGPS VFPLAPSSKS T SGGTAALG ...String: MDWTWRILFL VAAATGTHAQ MQLVQSGPEV KKPGTSVKVS CKASGFTFWS SAVQWVRQAR GQRLEWIGWI VIASGETNYA QKFQERVTI TRDMSTSTAY MELSSLRSED TAVYYCAAPY CSSRECNNGF DIWGQGTMVT VSSASTKGPS VFPLAPSSKS T SGGTAALG CLVKDYFPEP VTVSWNSGAL TSGVHTFPAV LQSSGLYSLS SVVTVPSSSL GTQTYICNVN HKPSNTKVDK KV EPKSCDK THTCPPCPAP ELLGGPSVFL FPPKPKDTLM ISRTPEVTCV VVDVSHEDPE VKFNWYVDGV EVHNAKTKPR EEQ YNSTYR VVSVLTVLHQ DWLNGKEYKC KVSNKALPAP IEKTISKAKG QPREPQVYTL PPSRDELTKN QVSLTCLVKG FYPS DIAVE WESNGQPENN YKTTPPVLDS DGSFFLYSKL TVDKSRWQQG NVFSCSVMHE ALHNHYTQKS LSLSPGK |
-Macromolecule #2: Ab#10-M30W-S94M light chain
| Macromolecule | Name: Ab#10-M30W-S94M light chain / type: protein_or_peptide / ID: 2 / Number of copies: 1 / Enantiomer: LEVO |
|---|---|
| Source (natural) | Organism: Homo sapiens (human) |
| Molecular weight | Theoretical: 25.939043 KDa |
| Recombinant expression | Organism: Homo sapiens (human) |
| Sequence | String: MVLQTQVFIS LLLWISGAYG EIVLTQSPGT LSLSPGERAT LSCRASQSVS SMDLAWYQQK PGQAPRLLIY YASSRATGIP DRFSGSGSG TDFTLTISRL EPEDFAVYYC QHYGGMRGWT FGQGTKVEIK RTVAAPSVFI FPPSDEQLKS GTASVVCLLN N FYPREAKV ...String: MVLQTQVFIS LLLWISGAYG EIVLTQSPGT LSLSPGERAT LSCRASQSVS SMDLAWYQQK PGQAPRLLIY YASSRATGIP DRFSGSGSG TDFTLTISRL EPEDFAVYYC QHYGGMRGWT FGQGTKVEIK RTVAAPSVFI FPPSDEQLKS GTASVVCLLN N FYPREAKV QWKVDNALQS GNSQESVTEQ DSKDSTYSLS NTLTLSKADY EKHKVYACEV THQGLSSPVT KSFNRGEC |
-Macromolecule #3: Spike protein
| Macromolecule | Name: Spike protein / type: protein_or_peptide / ID: 3 / Number of copies: 1 / Enantiomer: LEVO |
|---|---|
| Source (natural) | Organism: ![]() |
| Molecular weight | Theoretical: 22.264092 KDa |
| Recombinant expression | Organism: Homo sapiens (human) |
| Sequence | String: PNITNLCPFD EVFNATRFAS VYAWNRKRIS NCVADYSVLY NFAPFFAFKC YGVSPTKLND LCFTNVYADS FVIRGNEVSQ IAPGQTGNI ADYNYKLPDD FTGCVIAWNS NKLDGKVSGN YNYRYRLFRK SNLKPFERDI STEIYQAGNK PCNGVAGVNC Y FPLQSYSF ...String: PNITNLCPFD EVFNATRFAS VYAWNRKRIS NCVADYSVLY NFAPFFAFKC YGVSPTKLND LCFTNVYADS FVIRGNEVSQ IAPGQTGNI ADYNYKLPDD FTGCVIAWNS NKLDGKVSGN YNYRYRLFRK SNLKPFERDI STEIYQAGNK PCNGVAGVNC Y FPLQSYSF RPTYGVGHQP YRVVVLSFEL LHAPATVCG |
-Experimental details
-Structure determination
| Method | cryo EM |
|---|---|
Processing | single particle reconstruction |
| Aggregation state | particle |
-
Sample preparation
| Buffer | pH: 7.4 |
|---|---|
| Vitrification | Cryogen name: ETHANE |
-
Electron microscopy
| Microscope | TFS KRIOS |
|---|---|
| Image recording | Film or detector model: GATAN K3 (6k x 4k) / Average electron dose: 49.3 e/Å2 |
| Electron beam | Acceleration voltage: 300 kV / Electron source: FIELD EMISSION GUN |
| Electron optics | Illumination mode: SPOT SCAN / Imaging mode: BRIGHT FIELD / Nominal defocus max: 2.5 µm / Nominal defocus min: 0.5 µm |
| Experimental equipment | ![]() Model: Titan Krios / Image courtesy: FEI Company |
Movie
Controller
About Yorodumi




Keywords
Homo sapiens (human)
Authors
United States, 2 items
Citation




Z (Sec.)
Y (Row.)
X (Col.)




































Processing
FIELD EMISSION GUN

